<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmactu.fr/articles/digoxine-arrow-suspension-amm</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmactu</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-05-26T09:15:00+02:00</news:publication_date>
      <news:title>Digoxine Arrow 0,125 mg et 0,25 mg : l&apos;ANSM suspend l&apos;AMM à partir du 27 mai</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmactu.fr/articles/qalsody-charcot-has</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmactu</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-05-26T08:07:00+02:00</news:publication_date>
      <news:title>Qalsody (tofersen) : la HAS accorde un SMR faible conditionnel dans la SLA-SOD1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmactu.fr/articles/critical-medicines-act-europe</loc>
    <news:news>
      <news:publication>
        <news:name>Pharmactu</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-05-26T07:38:00+02:00</news:publication_date>
      <news:title>Critical Medicines Act : l&apos;Europe s&apos;attaque enfin aux ruptures de stock</news:title>
    </news:news>
  </url>
</urlset>
